Centrus Energy Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LEU research report →
Range $185 – $300
Price Chart
About the company
Centrus Energy Corp. is a global provider of essential nuclear fuel and associated services to the nuclear power industry, serving markets including the United States, Japan, and Belgium. The company operates through two primary divisions: Low-Enriched Uranium (LEU) and Technical Solutions.
- CEO
- Amir V. Vexler
- IPO
- 1998
- Employees
- 467
- HQ
- Bethesda, MD, US
AI snapshot
Six angles, distilled from the data.
The stock is in a strong rebound phase after a deep drawdown, but it still sits below its 200-day average, so the longer-term trend has not fully repaired. Price is working back toward the upper end of its 52-week range after spending much of the year well off the highs.
Street sentiment is mixed-to-cautious: the consensus is Hold, while the average target of 226.5 sits above the current share price. Recent calls have been split between reiterated Buys and fresh Holds, with UBS lifting its target to 185 and Barclays initiating at Equal Weight.
The earnings profile is uneven but improving. LEU has beaten in 5 of the last 8 quarters, including a 4.1% beat in August and a 288.9% beat in May, while next-year EPS estimates point higher to 3.746 from 1.81 TTM. Shareholders should watch whether margin and order execution can support that step-up.
No notable discretionary insider buying or selling. Recent filings are dominated by awards, exempt exercises, and in-kind tax withholding, including CEO and director equity grants plus CFO-related award and withholding activity, which reads more like routine compensation processing than a directional signal.
Profitability is solid but not yet high quality: gross margin is 23.7%, operating margin is 5.34%, and net margin is 10.23%. Growth remains constructive with revenue up 14% year over year, while EPS growth is still negative at -51.6% on a TTM basis.
LEU stands out as a niche uranium-fuel supplier with net cash of $742 million, giving it more balance-sheet flexibility than many capital-intensive energy names. The valuation is demanding at 83.49x earnings, so the setup favors execution over multiple expansion.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.28B
- P/E
- 68.88
- Fwd P/E
- 69.22
- PEG
- -1.17
- P/S
- 6.91
- P/B
- 4.07
- EV/EBITDA
- 35.57
- Div Yield
- 0.00%
- Gross Margin
- 23.27%
- Op Margin
- 1.56%
- Net Margin
- 10.23%
- ROE
- 7.06%
- ROIC
- 0.35%
Latest fiscal year · YoY change
- Revenue
- $448.70M+1.5%
- Gross Profit
- $117.50M+5.4%
- Op Income
- $50.20M
- Net Income
- $77.80M+6.3%
- EPS
- $4.33-3.6%
- OCF Growth
- +37.8%
- FCF Growth
- -4.9%
- 52W High
- $464.25
- 52W Low
- $142.13
- 50D MA
- $171.88
- 200D MA
- $217.50
- Beta
- 1.35
- RSI (14)
- 47
- Avg Volume
- 808.27K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Centrus said Q2 was strong on revenue and backlog growth, while rising LEU/HALEU demand and new contract wins helped reinforce its 2026 expansion plan.· August 6, 2026
- Q2 revenue was $176.1 million, up 14% year over year, with gross profit of $49.9 million and diluted EPS of $0.77.
- Backlog grew to $4.5 billion through 2040, including $3.7 billion in LEU and $0.8 billion in Technical Solutions.
- Management said all financial contingencies in contingent LEU enrichment backlog have been removed and the company is sufficiently funded for near-term needs, with $1.9 billion in unrestricted cash at quarter-end.
- The DOE signed a $900 million task order tied to commercial-scale production, and Centrus said it completed all HALEU production requirements under the existing demo contract two weeks ahead of schedule.
- 2026 guidance was reaffirmed for $450 million to $500 million of revenue and $350 million to $500 million of total capital spend; Piketon hiring guidance was raised to more than 175 net new employees and the first Oak Ridge centrifuge is expected in 2026.
Centrus reported Q2 2026 revenue of $176.1 million, up $21.6 million or 14% versus Q2 2025. Gross profit was $49.9 million versus $53.9 million in Q2 2025; operating income was $10.4 million; net income was $16.8 million versus $28.9 million; and diluted EPS was $0.77 versus $1.59. Adjusted net income was $38.7 million and adjusted diluted EPS was $1.77 versus $34.5 million and $1.90 in Q2 2025. LEU revenue was $153.4 million, up 22% year over year, while Technical Solutions revenue was $22.7 million, down 21%. The company ended Q2 with $1.9 billion in unrestricted cash and said total capital spend was $82.2 million, including $71.6 million of CapEx. For 2026, Centrus reaffirmed revenue guidance of $450 million to $500 million and total capital spend of $350 million to $500 million, raised Piketon workforce additions guidance to over 175 net new employees from over 100, kept Oak Ridge hiring guidance at at least 100 net new employees, and said it expects to complete its first centrifuge at Oak Ridge sometime in 2026.
Amir Vexler said the quarter showed strong demand across commercial LEU, national security, and HALEU, and he framed Centrus as benefiting from a widening supply-demand imbalance and rising LEU pricing. He emphasized that the DOE award and customer prepayments are helping fund the build-out without debt, while new HALEU commitments from Oklo and X-energy show the company is becoming the go-to supplier in that market. His tone was upbeat and execution-focused, repeatedly highlighting de-risking milestones, supply-chain progress, and the goal of restoring U.S. enrichment capacity at scale.
Todd Tinelli said results were in line with internal projections and were affected by the typical shift in contractual mix and the start of manufacturing-related spend. He cited $176.1 million of revenue, $49.9 million of gross profit, $16.8 million of net income, $38.7 million of adjusted net income, and $1.9 billion of unrestricted cash at quarter-end. He said second-quarter capital spend was $82.2 million, with $71.6 million in CapEx and $10.6 million in non-CapEx advanced technology costs, and noted that CapEx and non-CapEx spend should accelerate through the year. He also said all financial contingencies in contingent LEU enrichment backlog have been removed and the company believes it is sufficiently funded for near-term capital requirements.
Analysts focused on the X-energy and Oklo HALEU agreements, customer behavior ahead of the Russian import ban, backlog growth, pricing structure, lead-time reduction, and the pace of CapEx and hiring. Management said it could not disclose delivery timing or contract pricing, but stressed that the HALEU deals include prepayments and that definitive agreements and prepayments are becoming more common. On LEU, Amir said utilities are showing more interest as Centrus becomes a lower-risk new entrant and that demand is supporting a seller’s market; Todd added that utilities have largely secured near-term needs, while future-period contracting is still building. On build-out timing, management said commercial production remains targeted for 2029, with potential to compress timelines, and reiterated that lead-time reduction and cost-out efforts are central to the Palantir, EPC, and supply-chain work.
The bull case on this call is that Centrus is seeing demand improve across all of its markets while backlog, pricing, and customer commitments are moving in the company’s favor. Management highlighted a $4.5 billion backlog, no remaining financial contingencies in contingent backlog, a $900 million DOE task order, and new HALEU offtake progress with prepayments that can help fund expansion. They also pointed to rising LEU pricing, strong cash, and a first Oak Ridge centrifuge expected in 2026 as signs the build-out is advancing.
The main risks are that the business is still highly dependent on successful execution of a complex, first-of-a-kind build-out and that meaningful commercial production is not expected until 2029. Management said CapEx and non-CapEx spend will accelerate, advanced technology costs will continue to flow through the income statement, and the company is still working through supply-chain, lead-time, and staffing challenges. Analysts also pressed on contract timing, pricing, and whether customer demand is simply pulling forward purchases ahead of the Russian import ban, which leaves some uncertainty around how durable near-term order momentum will be.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.8%
- Shares Outstanding
- 18.95M
- Float Shares
- 18.91M
of shares held by institutions
427 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Van Eck Associates Corp | 1.65M | ▲ 441.91K |
| State Street Corp | 1.64M | ▲ 235.61K |
| Blackrock, Inc. | 1.55M | ▲ 59.66K |
| Mirae Asset Global Etfs Holdings Ltd. | 1.26M | ▲ 17.13K |
| Vanguard Group Inc | 1.09M | ▲ 14.32K |
| Vanguard Capital Management LLC | 809.19K | ▲ 6.50K |
| Geode Capital Management, LLC | 474.82K | ▲ 45.64K |
| Bank Of New York Mellon Corp | 406.77K | ▲ 25.81K |
| Dimensional Fund Advisors LP | 366.25K | ▲ 7.90K |
| Morgan Stanley | 303.52K | ▲ 146.59K |
| Renaissance Technologies LLC | 280.48K | ▲ 119.94K |
| Two Sigma Investments, LP | 235.30K | ▲ 100.53K |
Held by 280 ETFs
Biggest fund positions in LEU by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 11, 26 | TINELLI TODD M | other | 456 |
| Aug 11, 26 | TINELLI TODD M | other | 456 |
| Aug 11, 26 | TINELLI TODD M | other | 206 |
| Jun 17, 26 | NAGARAJAN NEAL KANTH | other | 0 |
| Jun 26, 26 | Williams Mikel H | other | 302 |
| Jun 26, 26 | Jonas Tina W | other | 293 |
| Jun 26, 26 | Madia William J | other | 345 |
| Jun 26, 26 | DONALD KIRKLAND H | other | 295 |
| Jun 26, 26 | Rothrock Ray A. | other | 235 |
| Jun 18, 26 | Williams Mikel H | other | 757 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our LEU coverage
Recent articles, reports, and earnings notes.

Our #1 Pick for 10X Potential, Revealed: What Stock Is Brian Hicks Teasing in Wealth Trust?
Brian Hicks of Angel Publishing’s Outsider Club is pitching “Our #1 Pick for 10X Potential,” also called Wealth Trust. We identify the uranium stock and test the 10X, AI and HALEU claims.

Standard Nuclear IPO: What Investors Need to Know
Standard Nuclear, Inc. (NYSE: STDN) is expected to list on 2026-07-16 on the NYSE at a price range of $18.00 to $21.00 per share. The company is offering 18,250,000 shares, with a disclosed market cap of $440,737,500. The bull case is a rare U.S. TRISO fuel platform tied to advanced reactors; the bear case is execution risk in a capital-intensive, highly regulated market.

newcleo's De-SPAC: What Investors Need to Know
newcleo, the advanced nuclear company developing lead-cooled fast reactors and MOX fuel, is going public through a merger with NewHold Investment Corp. III (Nasdaq: NHIC). The deal is expected to close in 2H 2026 and list on Nasdaq as NWCL. The setup offers a large PIPE and a shareholder-friendly promote structure, but investors should watch redemption risk, dilution, and the capital intensity of advanced nuclear.
Want a deeper read on LEU?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
NuScale Power and Oklo Drop 5%, Centrus Energy Sinks 6%: What's Behind the Nuclear Stock Selloff?
247wallst.com · Aug 20
2 Nuclear Stocks to Buy and What Each One Needs to Go Right
fool.com · Aug 19
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Abercrombie & Fitch, America Movil, Bath & Body Works, Duolingo, Gorilla Technology, Lumentum Holdings, Micron Technology, Tapestry,and More
247wallst.com · Aug 18
What Is the Best Nuclear Reactor Stock You Should Put $1,000 Into in 2026?
fool.com · Aug 17
The Bottlenecks of the Nuclear Fuel & Supply Chain
etftrends.com · Aug 17
Centrus Energy: Uncle Sam Won't Let His Centrifuge Fail
seekingalpha.com · Aug 13
Centrus Energy (LEU) Price Forecast: Can Backlog Conversion and a Falling Wedge Squeeze Price Higher?
fxempire.com · Aug 12
Centrus Energy (LEU) Forecast: Can Backlog Conversion and a Falling Wedge Squeeze Price Higher?
fxempire.com · Aug 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed August 19, 2026 · Live quote · Not investment advice